Knowing what a read-through means is a great way to spot winners that others may miss, Jim Cramer told his Mad Money viewers Thursday, but only if the company you're taking your cues from is credible.
Cramer said investors can learn a lot from Micron Technology's (MU) - Get Report conference call this quarter, as the company laid out for investors just how strong their business is becoming. Even with shares already up 58% for the year, Micron told investors that this quarter was the bottom and it will only get better from here.
What's the read-through? Cramer said if flash memory is strong, that means Western Digital (WDC) - Get Report can be bought. And if the data center is strong, that mean you should buy Advanced Micro Devices (AMD) - Get Report and Nvidia (NVDA) - Get Report. Cramer remains bullish on 5G wireless, recommending stocks like American Tower (AMT) - Get Report. He was also bullish on Facebook (FB) - Get Report and Alphabet (GOOGL) - Get Report.
Not all companies are credible, however. Cramer again called out FedEx (FDX) - Get Report as a serial disappointer. There is no read-through from the FedEx conference call, he said, as FedEx's problems are all their own. Darden Restaurants (DRI) - Get Report also disappointed in a self- inflicted way, Cramer said, with poor promotions and sloppy executions. The read-though from Darden is to buy Chipotle Mexican Grill (CMG) - Get Report.
Cramer and the AAP team are looking at everything from earnings and tariffs to the Federal Reserve. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.
The Market Isn't Always Right
Stocks are supposed to represent the future earnings potential of a company, and our stock market is designed to put a value on those those earnings using all of the information available at the time. It's a system that works perfectly, Cramer told viewers, except when it doesn't.
"The markets are a mess," Cramer quipped, and stocks are mis-priced all the time. Just look at ConAgra Foods (CAG) - Get Report, which shot up 19% over the past two weeks, he said. Back when the company announced the acquisition of Pinnacle Foods, investors panned the stock, calling the acquired brands like Bird's Eye vegetables and Duncan Hines tired and worthless. Yet in less than two years, ConAgra turned them into winners.
Finally, Cramer called out ViacomCBS (VIA) - Get Report, a stock that is now among the cheapest in the S&P 500. Even with increased streaming competition, Cramer said the markets are valuing Viacom all wrong.
On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.
IPOs of 2019
As 2019 winds to a close, is it time to take a second look at some of this year's hottest IPOs? Cramer said while most have been beaten down since their debut, there are a few diamonds in the rough.
Levi Strauss (LEVI) - Get Report is one of those gems. Shares ran from $17 to $22 a share before sliding to just over $16. But with solid revenue growth and a ton of innovation, Cramer said Levi is more than just a clothing company. He felt the stock was a buy.
In the ridesharing space, Cramer said Lyft (LYFT) - Get Report is getting its act together, and Uber Technologies (UBER) - Get Report is holding up remarkably well given the wave of insider selling. Cramer still thinks Uber should sell it non-core businesses, like UberEats, to make itself more attractive.
Many IPOs are still too pricey to own. That was Cramer's take on Zoom Video (ZM) - Get Report, which trades at 22 times sales, and CrowdStrike (CRWD) - Get Report, which is off 22% from its IPO price but still sells for 12x sales.
Executive Decision: Emergent BioSolutions
For his "Executive Decision" segment, Cramer spoke with Robert Kramer, CEO of Emergent BioSolutions (EBS) - Get Report, the vaccine maker that landed a $2 billion government contract to provide smallpox vaccines.
Kramer said our government remains vigilant about protecting its people and military from biologic threats and continues to stockpile items like vaccines to ensure they're prepared. The benefits of immunizing against known diseases far outweigh the risks, he said.
Our country also continues to fight the opioid epidemic, Kramer said, and 97% of insurance plans now cover Narcan, their treatment for opioid overdose. The U.S. government spent $1.8 billion last year on items like Narcan, but also invested heavily in education and awareness for the 21 million patients who are prescribed opioids every year.
Off the Tape: ThoughtSpot
In his "Off The Tape" segment, Cramer sat down with Sudheesh Nair, CEO of the privately-held data analytics company, ThoughtSpot.
Nair explained there have been two big trends over the past five years. Companies are collecting more data than ever before, especially from things and mobile devices, and they are moving all of that data to the cloud. That means new tools are needed to provide insights so companies can make better decisions.
Data is all about discovery. Every answer you get from your data often spawns 10 more questions. Companies need tools that let users explore and have machine learning to find answers even before they're asked.
Here's what Jim Cramer had to say about some of the stocks that callers offered up during the Mad Money Lightning Round Thursday evening:
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position in NVDA, FB, GOOGL, ABBV.